Dennis S. Meteny's most recent trade in Angiodynamic Inc was a trade of 7,060 Common Stock done . Disclosure was reported to the exchange on July 20, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Angiodynamic Inc | Dennis S. Meteny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jul 2022 | 7,060 | 122,978 (0%) | 0% | 0 | Common Stock | |
Angiodynamic Inc | Dennis S. Meteny | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.95 per share. | 12 Jul 2022 | 6,022 | 120,716 (0%) | 0% | 16.0 | 96,051 | Common Stock |
Angiodynamic Inc | Dennis S. Meteny | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2022 | 6,022 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Angiodynamic Inc | Dennis S. Meteny | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.02 per share. | 12 Jul 2022 | 4,798 | 115,918 (0%) | 0% | 20.0 | 96,056 | Common Stock |
Angiodynamic Inc | Dennis S. Meteny | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.64 per share. | 28 Jul 2021 | 5,726 | 117,865 (0%) | 0% | 14.6 | 83,829 | Common Stock |
Angiodynamic Inc | Dennis S. Meteny | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2021 | 5,726 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
Angiodynamic Inc | Dennis S. Meteny | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.43 per share. | 28 Jul 2021 | 3,171 | 114,694 (0%) | 0% | 26.4 | 83,810 | Common Stock |
Angiodynamic Inc | Dennis S. Meteny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2021 | 5,738 | 112,139 (0%) | 0% | 0 | Common Stock |